ER
Eramet S.a.
ERMAY · OTC
$4.99 +0.51% (+$0.03)
1M -8.78%
Market Cap 1.31B €
P/E Ratio -
Div. Yield -
ROE 50.30%
Bulios Fair Price
$6.66
33.5% upside
Current Price
$4.99
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ERMAY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
39 /100
Fair EV/EBITDA 24.64x
P/B 1.82x
P/S 0.48x
Growth
0 /100
Declining Rev. growth 18.11%
Book val. growth 26.13%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 53.36%
FCF margin 25.92%
Net margin 16.64%
Quality
7 /100
Poor ROIC 2.78%
Asset turnover 0.47x
ROE 50.30%
Debt
10 /100
High Debt/Equity 3.52x
Net debt/EBITDA 14.76x
Current ratio 1.37x
Stability
57 /100
Moderate Beta 0.95x
Profitable years 0
Rev. volatility 14.31%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ERMAY
Online
Sector
Basic Materials
Industry
Industrial Materials
CEO
Christel Bories
Employees
8,572
Headquarters
Paris